Cara Corp (TVRD) - מקדם חוב לטווח ארוך להון

Cara Therapeutics Inc (TVRD) relies on an impeccable reputation for developing treatments for severe pruritus associated with nephropathies, as evidenced by physician recognition. This daily price chart illustrates the asset's dynamics, with a value of 0.00. However, the business operates in a state of intense competition with industry behemoths that are investing colossal sums into the development of similar drug analogs.

This indicator measures the proportion of long-term liabilities relative to equity, determining the degree of financial leverage and the stability of the funding structure. Amid the loss of CMS bonus payments for Korsuva, the long-term debt-to-equity ratio reflects the ability of Cara Therapeutics Inc (TVRD) to service loans during a sharp contraction of the customer base, signaling asset quality and bankruptcy risks.